Ligand Pharmaceuticals
LGND
LGND
258 hedge funds and large institutions have $1.97B invested in Ligand Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 99 increasing their positions, 86 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1% more capital invested
Capital invested by funds: $1.95B → $1.97B (+$12.6M)
0.5% more ownership
Funds ownership: 96.46% → 96.96% (+0.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
258
Holding in Top 10
1
Calls
$999K
Puts
$860K
Top Buyers
| 1 | +$16.5M | |
| 2 | +$11.3M | |
| 3 | +$4.71M | |
| 4 |
Legal & General Group
London,
United Kingdom
|
+$4.66M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$4.18M |
Top Sellers
| 1 | -$6.89M | |
| 2 | -$6.52M | |
| 3 | -$6.37M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.14M |
| 5 |
BlackRock
New York
|
-$2.72M |
